Zeneca boosted by US approval for new breast cancer drug


City Editor

Zeneca took another step towards its goal of being the world's largest cancer drug group yesterday when it received clearance from the American Food and Drug Administration to market Arimidex, a new treatment for advanced breast cancer in post-menopausal women.

Analysts welcomed the final approval, which could lead to peak sales of Arimidex in perhaps five years of pounds 260m, a sizeable contribution to the company's pharmaceutical sales, just over pounds 2bn last year and forecast to reach pounds 3.3bn by 2000. The shares closed 6p higher at 1,252p.

Tom McKillop, chief executive of Zeneca's pharmaceuticals arm, said: "Current hormonal therapies for advanced breast cancer have limitations, particularly in terms of patient acceptability. Arimidex represents an effective and well-tolerated therapy."

He added that Zeneca, headed by David Barnes, would be evaluating the use of the drug in the treatment of early breast cancer, a much larger market. According to the American Cancer Society, an estimated 184,300 women will be diagnosed with breast cancer in 1996. Zeneca believes that, despite screening campaigns to detect the disease in its early stages, 18,000 women in the US have advanced breast cancer.

About one woman in eight is expected to develop breast cancer at some time in her lifetime. The market for hormonal therapies to treat breast cancer in America was valued at $300m in 1994. Arimidex is effective because of the way it counters the growth of tumours stimulated by the female hormone oestrogen. In post-menopausal women, one of the main targets for anti-cancer drugs is non-ovarian synthesis of oestrogen, a process that Arimidex blocks.

Zeneca has already submitted Arimidex for approval in all the main drugs markets around the world. The treatment is already available in the UK and further approvals are expected this year. The company generates about a third of its revenues from cancer treatments, which include Nolvadex, another breast cancer drug, which had sales in 1994 of pounds 350m. Approval was also received last October for Casodex, which combats advanced prostate cancer. Tomudex, the first new colorectal cancer treatment for 35 years, is expected to be launched in the UK in the first quarter of the year.

The good news on Arimidex comes hot on the heels of Zeneca's announcement just before Christmas that it planned a sharp increase in its spending on drugs research and development.

According to Peter Doyle, group research and development director, R&D spending ofabout pounds 550m a year, will grow faster than inflation and the proportion of group funds spent on drugs rather than agrochemicals will increase to about two thirds.

ebooksAn unforgettable anthology of contemporary reportage
CSKA Moscow celebrate after equalising with a late penalty

Arts and Entertainment
Life and Style

Company reveals $542m investment in start-up building 'a rocket ship for the mind'

Bourgogne wine maker Laboure-Roi vice president Thibault Garin (L) offers the company's 2013 Beaujolais Nouveau wine to the guest in the wine spa at the Hakone Yunessun spa resort facilities in Hakone town, Kanagawa prefecture, some 100-kilometre west of Tokyo
Arts and Entertainment
James Blunt's debut album Back to Bedlam shot him to fame in 2004

Singer says the track was 'force-fed down people's throats'

Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Helpdesk Analyst

£23000 per annum + pension and 22 days holiday: Ashdown Group: An established ...

Senior Helpdesk Analyst / Service Desk Co-ordinator

£27000 per annum + pension, 22 days holiday: Ashdown Group: An established ind...

Senior Pensions Administrator

£23000 - £26000 Per Annum: Clearwater People Solutions Ltd: Our client is curr...

Corporate Actions Administrator / Operations Administrator

£25 - 30k: Guru Careers: A Corporate Actions Administrator / Operations Admini...

Day In a Page

Two super-sized ships have cruised into British waters, but how big can these behemoths get?

Super-sized ships: How big can they get?

Two of the largest vessels in the world cruised into UK waters last week
British doctors on brink of 'cure' for paralysis with spinal cord treatment

British doctors on brink of cure for paralysis

Sufferers can now be offered the possibility of cure thanks to a revolutionary implant of regenerative cells
Let's talk about loss

We need to talk about loss

Secrecy and silence surround stillbirth
Will there be an all-female mission to Mars?

Will there be an all-female mission to Mars?

Women may be better suited to space travel than men are
Oscar Pistorius sentencing: The athlete's wealth and notoriety have provoked a long overdue debate on South African prisons

'They poured water on, then electrified me...'

If Oscar Pistorius is sent to jail, his experience will not be that of other inmates
James Wharton: The former Guard now fighting discrimination against gay soldiers

The former Guard now fighting discrimination against gay soldiers

Life after the Army has brought new battles for the LGBT activist James Wharton
Ebola in the US: Panic over the virus threatens to infect President Obama's midterms

Panic over Ebola threatens to infect the midterms

Just one person has died, yet November's elections may be affected by what Republicans call 'Obama's Katrina', says Rupert Cornwell
Premier League coaches join the RSC to swap the tricks of their trades

Darling, you were fabulous! But offside...

Premier League coaches are joining the RSC to learn acting skills, and in turn they will teach its actors to play football. Nick Clark finds out why
How to dress with authority: Kirsty Wark and Camila Batmanghelidjh discuss the changing role of fashion in women's workwear

How to dress with authority

Kirsty Wark and Camila Batmanghelidjh discuss the changing role of fashion in women's workwear
New book on Joy Division's Ian Curtis sheds new light on the life of the late singer

New book on Ian Curtis sheds fresh light on the life of the late singer

'Joy Division were making art... Ian was for real' says author Jon Savage
Sean Harris: A rare interview with British acting's secret weapon

Sean Harris: A rare interview with British acting's secret weapon

The Bafta-winner talks Hollywood, being branded a psycho, and how Barbra Streisand is his true inspiration
Tim Minchin, interview: The musician, comedian and world's favourite ginger is on scorching form

Tim Minchin interview

For a no-holds-barred comedian who is scathing about woolly thinking and oppressive religiosity, he is surprisingly gentle in person
Boris Johnson's boozing won't win the puritan vote

Boris's boozing won't win the puritan vote

Many of us Brits still disapprove of conspicuous consumption – it's the way we were raised, says DJ Taylor
Ash frontman Tim Wheeler reveals how he came to terms with his father's dementia

Tim Wheeler: Alzheimer's, memories and my dad

Wheeler's dad suffered from Alzheimer's for three years. When he died, there was only one way the Ash frontman knew how to respond: with a heartfelt solo album